🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,99 USD

Máx. histórico

178,74

2143 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,38%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+2,43%

Cierre anterior

18,54

Rango de hoy

18,52 – 19,26

Volumen hoy

1.328.200

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 1 día
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/07/2001 52,80 52,80 51,90 52,08 -0,80% 1,70% 5.000
19/07/2001 52,50 53,10 51,90 52,50 +0,57% 2,29% 4.100
18/07/2001 52,80 53,64 51,96 52,20 -1,58% 3,18% 14.233
17/07/2001 53,70 53,70 52,62 53,04 -1,23% 2,01% 17.467
16/07/2001 50,10 53,88 50,04 53,70 +5,79% 7,66% 22.700
13/07/2001 49,98 51,24 49,86 50,76 +0,83% 2,76% 10.167
12/07/2001 49,92 50,70 49,20 50,34 +0,84% 3,00% 7.867
11/07/2001 49,68 50,04 49,50 49,92 -0,24% 1,09% 9.200
10/07/2001 51,00 51,60 49,50 50,04 -2,00% 4,12% 9.167
09/07/2001 52,02 52,80 51,00 51,06 -0,47% 3,46% 9.467
06/07/2001 51,66 52,32 51,00 51,30 -1,95% 2,56% 4.633
05/07/2001 51,60 52,32 51,00 52,32 +1,40% 2,56% 4.150
03/07/2001 52,80 52,80 50,94 51,60 -0,35% 3,52% 2.750
02/07/2001 51,36 54,06 51,00 51,78 -12,39% 5,96% 44.483
29/06/2001 51,54 60,00 50,40 59,10 +13,22% 18,63% 133.600
28/06/2001 54,42 54,54 50,76 52,20 -4,08% 6,95% 40.983
27/06/2001 56,04 56,52 52,80 54,42 -2,99% 6,64% 19.833
26/06/2001 55,44 56,40 55,38 56,10 +0,65% 1,84% 14.950
25/06/2001 54,18 57,00 54,18 55,74 +1,53% 5,20% 18.367
22/06/2001 54,00 54,90 53,10 54,90 +1,67% 3,33% 27.167
21/06/2001 53,40 54,00 51,90 54,00 +2,86% 3,93% 9.250
20/06/2001 48,48 53,46 46,50 52,50 +6,84% 14,36% 24.167
19/06/2001 54,00 54,00 48,48 49,14 -8,90% 10,22% 19.933
18/06/2001 54,36 55,14 53,82 53,94 -0,11% 2,43% 6.483
15/06/2001 54,00 55,50 53,16 54,00 -0,99% 4,33% 11.367
14/06/2001 54,90 56,40 53,88 54,54 -1,62% 4,59% 15.800
13/06/2001 54,90 56,40 54,30 55,44 +0,65% 3,83% 14.017
12/06/2001 54,36 55,50 51,12 55,08 -0,11% 8,06% 28.317
11/06/2001 56,10 56,40 54,00 55,14 -0,65% 4,28% 13.350
08/06/2001 56,46 56,82 54,48 55,50 -0,86% 4,14% 15.350